Skip to content
Research To Practice | Oncology Videos cover art

All Episodes

Research To Practice | Oncology Videos — 1,000 episodes · page 6 of 10

#
Title
501

Breast Cancer | Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer

502

Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

503

Prostate Cancer | Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer

504

HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer

505

HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)

506

Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology

507

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation

508

Melanoma and Nonmelanoma Skin Cancers | Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review

509

Renal Cell Carcinoma | Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review

510

Colorectal Cancer | RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer

511

Lymphoma | RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

512

Triple-Negative Breast Cancer | What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer

513

Multiple Myeloma | Breakfast with the Investigators: New Advances in Multiple Myeloma

514

Lung Cancer | Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer

515

Myelofibrosis | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis

516

Prostate Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Prostate Cancer

517

Metastatic Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Metastatic Breast Cancer

518

Ovarian and Endometrial Cancer | Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Ovarian and Endometrial Cancer

519

Antibody-Drug Conjugates | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Optimal Implementation of Antibody-Drug Conjugates

520

Hepatobiliary Cancers | Lunch with the Investigators: Hepatobiliary Cancers

521

Non-Small Cell Lung Cancer | Second Opinion: Investigators Discuss How They Apply Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer with an EGFR Mutation

522

Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

523

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer'

524

Chronic Lymphocytic Leukemia and Lymphoma | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Chronic Lymphocytic Leukemia and Bispecific Antibodies in the Management of Lymphoma

525

Breast Cancer | Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer

526

Non-Small Cell Lung Cancer | Justin F Gainor, MD

527

Non-Small Cell Lung Cancer | Karen Reckamp, MD, MS

528

Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

529

Gastroesophageal and Colorectal Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Gastroesophageal and Colorectal Cancers

530

Urothelial Bladder Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer

531

Myelofibrosis | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Myelofibrosis

532

Ovarian Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Ovarian Cancer

533

Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer

534

Prostate Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Prostate Cancer

535

Lymphoma | Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences

536

Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Companion Faculty Lecture)

537

Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

538

Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)

539

Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma

540

Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers

541

HER2-Positive Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

542

Endometrial Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Endometrial Cancer

543

Prostate Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Prostate Cancer

544

Acute Myeloid Leukemia | Naval Daver, MD

545

Acute Myeloid Leukemia | Courtney D DiNardo, MD, MSCE

546

Acute Myeloid Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

547

Non-Small Cell Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation

548

Metastatic Triple-Negative Breast Cancer | Virtual Case Library: Metastatic Triple-Negative Breast Cancer

549

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

550

Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer (Companion Faculty Lecture)

551

Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

552

Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

553

Endometrial Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Endometrial Cancer

554

Paroxysmal Nocturnal Hemoglobinuria | Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

555

Prostate Cancer | Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

556

Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

557

Pancreatic Cancer | Third Annual National General Medical Oncology Summit

558

Colorectal Cancer | Third Annual National General Medical Oncology Summit

559

Hepatobiliary Cancers | Third Annual National General Medical Oncology Summit

560

Gastroesophageal Cancers | Third Annual National General Medical Oncology Summit

561

Multiple Myeloma | Third Annual National General Medical Oncology Summit

562

Nontargeted Treatments for Lung Cancer | Third Annual National General Medical Oncology Summit

563

Targeted Therapy for Non-Small Cell Lung Cancer | Third Annual National General Medical Oncology Summit

564

Prostate Cancer | Third Annual National General Medical Oncology Summit

565

Urothelial Bladder Cancer | Third Annual National General Medical Oncology Summit

566

Renal Cell Carcinoma | Third Annual National General Medical Oncology Summit

567

Metastatic HER2-Positive and Triple-Negative Breast Cancer | Third Annual National General Medical Oncology Summit

568

Localized Breast Cancer | Third Annual National General Medical Oncology Summit

569

Gynecologic Cancers | Third Annual National General Medical Oncology Summit

570

Hodgkin and Non-Hodgkin Lymphoma | Third Annual National General Medical Oncology Summit

571

ER-Positive Metastatic Breast Cancer | Third Annual National General Medical Oncology Summit

572

Ovarian Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Ovarian Cancer

573

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition (Companion Faculty Lecture)

574

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

575

Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

576

Colorectal Cancer | Arvind Dasari, MD, MS

577

Colorectal Cancer | Thierry André, MD

578

Colorectal Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

579

Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD

580

Urothelial Bladder Cancer | Shilpa Gupta, MD

581

Urothelial Bladder Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

582

B7-H3-Targeted Antibody-Drug Conjugates | Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

583

Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

584

Prostate Cancer | Andrew J Armstrong, MD, ScM

585

Prostate Cancer | Maha Hussain, MD, FACP, FASCO

586

Lymphoma | Andrew M Evens, DO, MBA, MSc

587

Lymphoma | Sonali M Smith, MD

588

Lymphoma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

589

ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

590

Hepatobiliary Cancers | Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

591

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

592

HER2-Positive and Triple-Negative Breast Cancer | Priyanka Sharma, MD

593

HER2-Positive and Triple-Negative Breast Cancer | Ian E Krop, MD, PhD

594

HER2-Positive and Triple-Negative Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

595

Metastatic Urothelial Bladder Cancer | Virtual Case Library: Metastatic Urothelial Bladder Cancer

596

ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer (Companion Faculty Lecture)

597

ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer

598

Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series

599

Gastroesophageal Cancers | Yelena Y Janjigian, MD

600

Gastroesophageal Cancers | Zev Wainberg, MD, MSc